myomectomy surgery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - age ranging from 18 to 50 years with documented uterine fibroids on pelvic imaging (pelvic ultrasound or MRI) within last 12 months, - patients complaining of abnormal vaginal bleeding, chronic pelvic pain, pressure symptoms or reproductive disorders - pre-operative hemoglobin > 8g/dl.
Exclusion criteria
Exclusion criteria: - post-menopausal women - patients previously treated with Depo-Lupron, Depo-Provera or oral contraceptive pills, - patients with known bleeding/clotting disorders, active liver, kidney or cardiovascular disease or receiving anticoagulant, NSAIDs or antiplatelet, - previous history of gynecological malignancy, - previous abdominal myomectomy or venous thromboembolism.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Studying the effect of tranexamic acid versus carbetocin on operative blood loss ( intra-and post operative ) and the needs of blood transfusion in women undergoing myomectomy. | — |
Secondary
| Measure | Time frame |
|---|---|
| the need for blood transfusion, patients hemoglobin level after the operation | — |
Countries
Egypt
Contacts
suez canal university